异位胰蛋白酶在动脉粥样斑块中的表达分布及其与斑块稳定性关系的探索

潘海燕, 司国君, 吴晓晖. 异位胰蛋白酶在动脉粥样斑块中的表达分布及其与斑块稳定性关系的探索[J]. 临床心血管病杂志, 2018, 34(5): 507-512. doi: 10.13201/j.issn.1001-1439.2018.05.019
引用本文: 潘海燕, 司国君, 吴晓晖. 异位胰蛋白酶在动脉粥样斑块中的表达分布及其与斑块稳定性关系的探索[J]. 临床心血管病杂志, 2018, 34(5): 507-512. doi: 10.13201/j.issn.1001-1439.2018.05.019
PAN Haiyan, SI Guojun, WU Xiaohui. Expression and distribution of ectopic trypsin in the atherosclerotic plaques and its potential impacts on plaque stability[J]. J Clin Cardiol, 2018, 34(5): 507-512. doi: 10.13201/j.issn.1001-1439.2018.05.019
Citation: PAN Haiyan, SI Guojun, WU Xiaohui. Expression and distribution of ectopic trypsin in the atherosclerotic plaques and its potential impacts on plaque stability[J]. J Clin Cardiol, 2018, 34(5): 507-512. doi: 10.13201/j.issn.1001-1439.2018.05.019

异位胰蛋白酶在动脉粥样斑块中的表达分布及其与斑块稳定性关系的探索

  • 基金项目:

    南通市市级科技计划项目 (No:MS12017003-1)

详细信息
    通讯作者: 潘海燕,E-mail:dr.phy@qq.com
  • 中图分类号: R541.4

Expression and distribution of ectopic trypsin in the atherosclerotic plaques and its potential impacts on plaque stability

More Information
  • 目的:探讨动脉粥样斑块组织中异位胰蛋白酶的表达分布及其对斑块稳定性的潜在影响。方法:20只8周龄雄性新西兰白兔随机分入对照组和动脉粥样硬化实验组 (实验组), 每组10只。对照组予普通饲料, 实验组予高胆固醇高脂饲料, 持续喂养17周后处死, 切取主动脉和冠状动脉组织, 分别进行病理和生化检查。结果:实验组的主动脉及冠状动脉组织中异位胰蛋白酶、基质金属蛋白酶-9 (MMP-9) 及促炎细胞因子白细胞介素 (IL) -6、IL-β及肿瘤坏死因子α (TNF-α) 表达较对照组显著上调 (均P<0.01);激活型MMP-9 (actMMP-9) 与前体型MMP-9 (proMMP-9) 的比值显著增高 (P<0.05);粥样斑块组织内可见异位胰蛋白酶大量表达, 上调的异位胰蛋白酶与MMP-9分布一致, 均主要分布在粥样斑块中。结论:作为proMMP-9的有效激动剂, 动脉粥样斑块组织中大量表达的异位胰蛋白酶可能是引发粥样斑块炎症反应及破裂的一个重要因素。
  • 加载中
  • [1]

    Papazafiropoulou A,Tentolouris N.Matrix metalloproteinases and cardiovascular diseases[J].Hippokratia,2009,13(2):76-82.

    [2]

    Pan HY,Yamada H,Chida J,et al.Up-regulation of ectopic trypsins in the myocardium by influenza A virus infection triggers acute myocarditis[J].Cardiovasc Res,2011,89(3):595-603.

    [3]

    Pan HY,Sun HM,Xue LJ,et al.Ectopic trypsin in the myocardium promotes dilated cardiomyopathy after influenza A virus infection[J].Am J Physiol Heart Circ Physiol,2014,307(6):H922-932.

    [4]

    Qamar J.Clinical Implications of Tumor Necrosis Factor-Alpha,Interleukin-6 and Resistin in Coronary Artery Disease[J].World J Cardiovasc Dis,2014,4(9):416-421.

    [5]

    陈羽乔,叶飞.超敏C反应蛋白与冠状动脉内薄纤维帽粥样斑块相关性研究进展[J].临床心血管病杂志,2017,33(8):773-777.

    [6]

    Hansson GK.Inflammation,atherosclerosis,and coronary artery disease[J].N Engl J Med,2005,352(16):1685-1695.

    [7]

    Crea F,Liuzzo G.Anti-inflammatory treatment of acute coronary syndromes:the need for precision medicine[J].Eur Heart J,2016,37(30):2414-2416.

    [8]

    Ljung L,Simard JF,Jacobsson L,et al.Anti-Rheumatic Therapy in Sweden (ARTIS) Study Group.Treatment with tumor necrosis factor inhibitors and the risk of acute coronary syndromes in early rheumatoid arthritis[J].Arthritis Rheum,2012,64(1):42-52.

    [9]

    蔡海荣,黄玉萍,袁康,等.灯盏细辛注射液对动脉硬化家兔脂代谢、内皮功能及MMP-9/TIMP-1表达的影响[J].临床心血管病杂志,2017,33(10):1000-1003.

    [10]

    Ramos-desimone N,Hahn-dantona E,Sipley J,et al.Activation of matrix metalloproteinase-9(MMP-9) via a converging plasmin/stromelysin-1 cascade enhances tumor cell invasion[J].J Biol Chem,1999,274(19):13066-13076.

    [11]

    Christensen J,Shastri VP.Matrix-metalloproteinase-9 is cleaved and activated by cathepsin K[J].BMC Res Notes,2015,8:322.

    [12]

    O'sullivan S,Medina C,Ledwidge M,et al.Nitric oxide-matrix metaloproteinase-9 interactions:biological and pharmacological significance——NO and MMP-9 interactions[J].Biochim Biophys Acta,2014,1843(3):603-617.

    [13]

    Shekhonin BV,Domogatsky SP,Muzykantov VR,et al.Distribution of type Ⅰ,Ⅲ,Ⅳ and Ⅴ collagen in normal and atherosclerotic human arterial wall:immunomorphological characteristics[J].Coll Relat Res,1985,5(4):355-368.

    [14]

    Bigg HF,Rowan AD,Barker MD,et al.Activity of matrix metalloproteinase-9 against native collagen types Ⅰ and Ⅲ[J].FEBS J,2007,274(5):1246-1255.

    [15]

    Nagase H,VISSE R,MURPHY G.Structure and function of matrix metalloproteinases and TIMPs[J].Cardiovasc Res,2006,69(3):562-573.

    [16]

    Galicka A,Wo? czyński S,Gindzieński A.Studies on type Ⅰ collagen in skin fibroblasts cultured from twins with lethal osteogenesis imperfect[J].Acta Biochim Pol,2003,50(2):481-488.

    [17]

    Koshikawa N,Hasegawa S,Nagashima Y,et al.Expression of trypsin by epithelial cells of various tissues,leukocytes,and neurons in human and mouse[J].Am J Pathol,1998,153(3):937-944.

    [18]

    周千星,袁春菊,鄢高亮.蛋白酶激活受体-2对动脉粥样硬化斑块发展和稳定性作用的实验研究[J].中国临床药理学与治疗学,2016,21(11):1233-1238.

    [19]

    Miike S,Mcwilliam AS,Kita H.Trypsin induces activation and inflammatory mediator release from human eosinophils through protease-activated receptor-2[J].J Immunol,2001,167(11):6615-6622.

    [20]

    Nguyen TD,Moody MW,Steinhoff M,et al.Trypsin activates pancreatic duct epithelial cell ion channels through proteinase-activated receptor-2[J].J Clin Invest,1999,103(2):261-269.

    [21]

    Suen JY,Gardiner B,Grimmond S,et al.Profiling gene expression induced by protease-activated receptor 2(PAR2) activation in human kidney cells[J].PLoS One,2010,5(11):e13809.

  • 加载中
计量
  • 文章访问数:  167
  • PDF下载数:  32
  • 施引文献:  0
出版历程
收稿日期:  2017-11-10

目录